Multiple Myeloma, Susceptibility to, Somatic Mutation
|
Multiple Myeloma, Resistance to, Somatic Mutation
|
Multiple Myeloma Without Mention of Remission
|
Multiple Myeloma/plasma Cell Myeloma
|
Immunoglobulin Deposition Disease
|
Myeloid Neoplasm of Plasma Cell
|
Myeloma, Plasma Cell, Malignant
|
Monostotic Plasma Cell Myeloma
|
Primary Systemic Amyloidosis
|
Plasma Cell Myeloid Neoplasm
|
Kahler-Bozzolo Disease
|
Plasma Cell Neoplasm
|
Plasma Cell Myelomas
|
Multiple Myeloma Nos
|
Primary Amyloidosis
|
Plasmacytic Myeloma
|
Multiple Myelomata
基础信息
疾病表征
基因 & 突变
靶点药物
疾病模型
文献报道
Multiple myeloma is a cancer of plasma cells in the bone marrow, characterized by abnormal cell growth leading to tumors in bones, bone pain, fractures, weakness, and fatigue. Symptoms may include frequent infections, thirst, and urination. Diagnosis involves lab tests and imaging, with treatment options such as chemotherapy, stem cell transplantation, radiation, or targeted therapy. The disorder can cause anemia, weakened immune system, kidney problems, and hypercalcemia. It is more common in older individuals, African Americans, and those with a family history of the condition.